DST Diagnostische Systeme & Technologien
DST Diagnostische Systeme & Technologien GmbH, an AESKU Group subsidiary based in Schwerin, Germany, manufactures and markets in-vitro diagnostic kits and over 600 allergen extracts for allergy and food intolerance testing, serving medical laboratories, practitioners, and IVD manufacturers globally.
- Company typePrivate
- Founded2005
- HeadquartersSchwerin, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What DST Diagnostische Systeme & Technologien does
DST Diagnostische Systeme & Technologien GmbH is a German specialty in-vitro diagnostics (IVD) manufacturer focused on allergy and food intolerance testing. Founded in 2005 and headquartered in Schwerin, the company develops, manufactures, and markets a portfolio of ELISA kits, allergen extracts, line immunoassays, and near-patient rapid tests organized under five sub-brands: allergia (specific IgE ELISA), NutriLAB (specific IgG4/IgG ELISA), ALLERGY LINE (LIA), NutriSMART (rapid food intolerance test detecting 57 foods in parallel), and FastCheckPOC (point-of-care allergy tests). The company operates as a subsidiary of the AESKU Group, with products designed to interoperate with AESKU.Diagnostics analysis systems.
The company's technical foundation is its in-house allergen manufacturing capability: over 600 lyophilized food, respiratory, environmental, native, and recombinant allergen extracts are produced at the Schwerin facility, each accompanied by a quality certificate documenting protein content via the Lowry method. All manufacturing operates under EN ISO 13485 certification granted by TÜV Rheinland. The product range spans high-throughput laboratory formats - pre-coated microtiter plates in 44, 88, 184, and 280-food panels with 2-hour assay times and sub-microliter sample volumes - down to bedside rapid tests. The company also operates a diagnostic laboratory service that accepts blood, serum, plasma, or saliva samples from healthcare professionals and patients worldwide, running food intolerance, vitamin D/B12, cortisol, histamine intolerance, celiac disease, ferritin, cholesterol, lactose intolerance, and allergy panels.
DST monetizes through one-time product sales (IVD kits, allergen extracts, rapid tests) to medical laboratories, healthcare practitioners, and other IVD manufacturers, alongside fee-for-service laboratory testing. Distribution combines direct sales ([email protected]) with a worldwide distributor network; pricing is quote-based and not publicly disclosed. The company is privately held under German GmbH structure with no disclosed funding rounds, ownership changes, or revenue figures, and is led by CEO Dr. Torsten Matthias.
DST Diagnostische Systeme & Technologien firmographics
Firmographics- Name
- DST Diagnostische Systeme & Technologien
- Legal name
- DST Diagnostische Systeme & Technologien GmbH
- Website
- https://dst-diagnostic.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- DST Diagnostische Systeme & Technologien GmbH, an AESKU Group subsidiary based in Schwerin, Germany, manufactures and markets in-vitro diagnostic kits and over 600 allergen extracts for allergy and food intolerance testing, serving medical laboratories, practitioners, and IVD manufacturers globally.
- Ownership category
- akta.pro rank
DST Diagnostische Systeme & Technologien industry classification
Industry- Product category
- In-Vitro Diagnostics (Allergy & Food Intolerance)
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)
- akta.pro secondary industries
- Autoimmune & Allergy Diagnostics (HLAAALAK), Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT) (HLAKAAAL), Food Allergy Evaluation & Management (HLAKAAAD)
Keywords
Where DST Diagnostische Systeme & Technologien is headquartered
LocationHeadquarters
- HQ city
- Schwerin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
DST Diagnostische Systeme & Technologien business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- IVD Products: Sale of in-vitro diagnostic products including ELISA kits, allergen extracts, and rapid tests for allergy and food intolerance diagnostics.
- Laboratory Testing Services: Specialized diagnostic laboratory service accepting blood, serum, plasma or saliva samples from patients and healthcare professionals worldwide, providing detailed test reports and dietary recommendations.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels3 records
DST Diagnostische Systeme & Technologien product offering
Product offeringCore offering
DST Diagnostische Systeme & Technologien develops, manufactures, and markets in-vitro diagnostic (IVD) products for allergy and food intolerance diagnostics. The portfolio comprises ELISA kits (Allergia for specific IgE detection and NutriLAB for IgG4/IgG detection), 600+ lyophilized allergen extracts (food, respiratory, environmental, native, and recombinant), Line Immunoassay kits (ALLERGY LINE for sIgE and sIgG4), point-of-care rapid tests (FastCheckPOC 20 and NutriSMART covering 57 foods), and a specialized in-house laboratory testing service that processes patient and clinician samples globally.
Product overview
DST Diagnostische Systeme & Technologien is an in-vitro diagnostic manufacturer based in Germany offering a comprehensive portfolio of allergy and food intolerance diagnostic products. The product lineup includes three main categories: ELISA-based laboratory tests (Allergia sIgE ELISA Kits, NutriLAB ELISA Kits), rapid Point-of-Care tests (FastCheckPOC® 20, NutriSMART®), and Line Immunoassay (LIA) kits (ALLERGY LINE sIgE, ALLERG4Y LINE sIgG4). Complementing these are over 600 allergen extracts (food, respiratory, environmental, native and recombinant) manufactured in-house, and a specialized laboratory service accepting patient samples worldwide for comprehensive testing. The products range from high-throughput laboratory formats (microtiter plates with 44-280 food panels) to rapid bedside tests, serving both laboratory and point-of-care healthcare settings.
Differentiator
Problem solved
Functional benefit
Brands
- allergia: ELISA kits for detection of specific IgE
- NutriLAB
- ALLERGY LINE
- NutriSMART
- FastCheckPOC
Products and services
- Allergia sIgE ELISA Kits ELISA kits for the detection of specific IgE (sIgE) and total IgE antibodies in patient samples, used by clinical and research laboratories for allergy diagnostics.
- NutriLAB ELISA Kits ELISA kits for the detection of specific IgG4 and specific IgG antibodies used for diagnosing food intolerances. Available in panel sizes of 44, 88, 184, and 280 foods with food extracts manufactured in-house and pre-coated microtiter plates compatible with common plate readers and automated/semi-automated ELISA analyzers.
- Allergen Extracts Over 600 lyophilized allergen extracts covering food allergens, respiratory/inhalation allergens, environmental allergens, native major allergens, and recombinant allergens. Available in 1mg, 5mg, and 10mg glass vials and manufactured at DST's Schwerin facility without cytotoxic chemicals, stabilizers, or preservatives; supplied with a quality certificate proving protein content (Lowry method).
- FastCheckPOC 20 Point-of-Care (POC) rapid test for allergy diagnosis designed to provide immediate results for healthcare practitioners during the patient consultation.
- NutriSMART Rapid point-of-care test for food intolerances that simultaneously detects 57 foods in parallel, intended for use by healthcare practitioners in a clinical setting.
- ALLERGY LINE sIgE Kits Line Immunoassay (LIA) kits for the detection of specific IgE antibodies in patient samples, providing an alternative format to ELISA for laboratory allergy diagnostics.
- ALLERG4Y LINE sIgG4 Kits Line Immunoassay kits for the detection of specific IgG4 antibodies in patient samples, used for food intolerance diagnostics in laboratory settings.
- Laboratory Testing Service Specialty in-house diagnostic laboratory offering testing services including food intolerance tests (22, 44, 88, 184, 280 food panels), vitamin D, vitamin B12, cortisol, histamine intolerance, celiac disease, ferritin, cholesterol, lactose intolerance, and allergy tests. Receives blood, serum, plasma, or saliva samples from laboratories, healthcare professionals, and patients worldwide and returns detailed test reports and dietary recommendations.
Quantifiable outcome
- Shelf life of up to 10 years at -20°C for allergen extracts
- +2 more outcomes
Companies that use DST Diagnostische Systeme & Technologien
Customer profileSegments4 records
Ideal customer profiles4 records
DST Diagnostische Systeme & Technologien technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
DST Diagnostische Systeme & Technologien partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- AESKU GroupcoreDST is a company belonging to the AESKU Group. The AESKU Group specializes in allergy diagnostics and related IVD products. DST operates as a subsidiary within this group of companies.
- AESKU.Diagnostics GmbH & Co. KGcoreAnalysis systems manufactured by AESKU are designed for use with analysis products of DST and AESKU.Diagnostics. Products are compatible within the group ecosystem.
- TÜV RheinlandcoreIndependent certification body that certifies DST's quality management system according to ISO 13485 standards for medical device manufacturing.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
DST Diagnostische Systeme & Technologien competitors and assessment
Company assessmentBroad incumbents
- BioMérieux: BioMérieux is a major in vitro diagnostics company with allergy, infectious disease and industrial microbiology testing portfolios. As a broad incumbent, it overlaps with DST's IVD distribution into clinical labs but at substantially larger scale and with a more diversified product range.
- Thermo Fisher Scientific (ImmunoCAP): Thermo Fisher's ImmunoCAP is the global gold standard in specific IgE allergy diagnostics. As a broad life-sciences incumbent, it overlaps with DST's allergy IVD portfolio but at vastly greater scale and with deeper clinical guideline entrenchment.
- Siemens Healthineers: Siemens Healthineers offers allergy and infectious disease immunoassays on its Atellica/ADVIA Centaur platforms. As a diversified diagnostics incumbent, it competes with DST for central-lab allergy testing workloads but is not specialized in food intolerance/IgG panels.
Direct peers
- Omega Diagnostics: Omega Diagnostics (now part of Cambridge Nutritional Sciences) is a UK-based specialty IVD company focused on food intolerance and allergy ELISA testing, including IgG-based panels. It is one of the most direct mid-market competitors to DST's NutriLAB offering.
- EUROIMMUN: EUROIMMUN (a PerkinElmer company) is a direct competitor in autoimmune and allergy IVD, offering comparable ELISA and immunoblot platforms. It is the closest functional mirror to DST in allergy/autoimmune diagnostic kits and is the most relevant competitive benchmark.
- AESKU.Diagnostics: AESKU.Diagnostics is a sister company within the AESKU Group that produces analyzers and allergy/autoimmune IVD reagents. Despite the parent-subsidiary link, it competes in the same product category and shares the same allergen R&D base, making it the most functionally comparable peer.
- R-Biopharm: R-Biopharm is a German specialty IVD manufacturer with strong food allergen and clinical diagnostics lines (including ELISA kits). It directly overlaps with DST's allergen extract manufacturing and food allergen testing business and competes in the same German and European channels.
- IDS (Immunodiagnostic Systems): IDS develops specialty immunoassays, including allergy diagnostics. As a mid-size specialty IVD player, it competes with DST for niche allergy panel contracts in European hospital and reference-lab settings.
Emerging players
- HYCOR Biomedical: HYCOR Biomedical develops allergy and autoimmune IVD products with a focus on IgE testing on its NOVEOS platform. It is comparable to DST as a specialty allergy IVD challenger but differentiates via its proprietary automated platform rather than ELISA/POC breadth.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
DST Diagnostische Systeme & Technologien compliance and trust
Trust signalCompliance2 records
DST Diagnostische Systeme & Technologien financial estimates
Financial estimateRevenue estimate
Valuation estimate
DST Diagnostische Systeme & Technologien leadership team
Management profileNumber of profiles
Profiles1 record
DST Diagnostische Systeme & Technologien funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DST Diagnostische Systeme & Technologien M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DST Diagnostische Systeme & Technologien
What does DST Diagnostische Systeme & Technologien do?
DST Diagnostische Systeme & Technologien develops, manufactures, and markets in-vitro diagnostic (IVD) products for allergy and food intolerance diagnostics. The portfolio comprises ELISA kits (Allergia for specific IgE detection and NutriLAB for IgG4/IgG detection), 600+ lyophilized allergen extracts (food, respiratory, environmental, native, and recombinant), Line Immunoassay kits (ALLERGY LINE for sIgE and sIgG4), point-of-care rapid tests (FastCheckPOC 20 and NutriSMART covering 57 foods), and a specialized in-house laboratory testing service that processes patient and clinician samples globally.
Is DST Diagnostische Systeme & Technologien a public or private company?
DST Diagnostische Systeme & Technologien is a private company. It is classified as corporate owned and is currently operating.
When was DST Diagnostische Systeme & Technologien founded?
DST Diagnostische Systeme & Technologien was founded in 2005. It employs 11 to 50 people.
Where is DST Diagnostische Systeme & Technologien based?
DST Diagnostische Systeme & Technologien is headquartered in Schwerin, Germany, in the Europe region.
How does DST Diagnostische Systeme & Technologien make money?
Two revenue lines are on record. IVD Products are the primary driver. The others are laboratory Testing Services.
Who are DST Diagnostische Systeme & Technologien's main competitors?
Broad incumbents on record are BioMérieux, Thermo Fisher Scientific (ImmunoCAP) and Siemens Healthineers. Direct peers are Omega Diagnostics, EUROIMMUN, AESKU.Diagnostics, R-Biopharm and IDS (Immunodiagnostic Systems). HYCOR Biomedical is listed as an emerging player.
Does DST Diagnostische Systeme & Technologien have an API?
No public API is recorded for DST Diagnostische Systeme & Technologien.
What industry is DST Diagnostische Systeme & Technologien in?
DST Diagnostische Systeme & Technologien's product category is In-Vitro Diagnostics (Allergy & Food Intolerance). Its primary akta.pro industry code is HLAHAAAK, Autoimmune, Allergy & Specialized Immunology Diagnostics, with a secondary code of HLAAALAK, Autoimmune & Allergy Diagnostics. Its NAICS code is 325413 and its SIC code is 2835.